Patents by Inventor Patrick O'Connor

Patrick O'Connor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110182925
    Abstract: The invention provides Ehrlichia canis antigens that can be used to detect E. canis infected animals regardless of whether the animals have been vaccinated for E. canis. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.
    Type: Application
    Filed: January 21, 2011
    Publication date: July 28, 2011
    Inventors: Eugene Regis Krah III, Melissa Beall, Thomas Patrick O'Connor, JR., Ramaswamy Chandrashekar
  • Patent number: 7964366
    Abstract: The invention provides methods and compositions for the detection of Ehrlichia chaffeensis.
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: June 21, 2011
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Thomas Patrick O'Connor, Jr., Eugene Regis Krah, III, Jill M. Saucier
  • Publication number: 20110124717
    Abstract: Methods for promoting osteogenesis to accelerate or enhance bone fracture healing, treat bone defects, and enhance bone formation are disclosed. The methods modulate an arachidonic acid metabolic or signaling pathway in general, and, in particular, utilize 5-lipoxygenase inhibitors. These molecules can be delivered alone or in combination with one or more agents that inhibit bone resorption, regulate calcium resorption from bone, enhance bone accumulation, enhance bone formation, induce bone formation, impair growth of microorganisms, reduce inflammation, and/or reduce pain.
    Type: Application
    Filed: November 5, 2010
    Publication date: May 26, 2011
    Applicant: ACCELALOX, INC.
    Inventor: James Patrick O'Connor
  • Publication number: 20110105959
    Abstract: Methods for promoting osteogenesis to accelerate or enhance bone fracture healing, treat bone defects, and enhance bone formation are disclosed. The methods rely on in vivo or ex vivo modulation of an arachidonic acid metabolic or signaling pathway in general, and, in particular, utilize 5-lipoxygenase inhibitors, leukotriene A4 hydrolase inhibitors, and/or leukotriene B4 receptor antagonists. These molecules can be delivered alone or in combination with one or more agents that inhibit bone resorption, regulate calcium resorption from bone, enhance bone accumulation, enhance bone formation, induce bone formation, impair growth of microorganisms, reduce inflammation, and/or reduce pain.
    Type: Application
    Filed: August 20, 2010
    Publication date: May 5, 2011
    Applicant: ACCELALOX, INC.
    Inventor: James Patrick O'Connor
  • Patent number: 7936033
    Abstract: According to one embodiment, a micro-optical device includes an electro-optical circuit and an annular frame disposed on a surface of a substrate. The electro-optical circuit has an active region that is encapsulated by a window and an interconnect region adjacent at least one edge of the electro-optical circuit. The annular frame extends around an outer periphery of the window and is separated from the window by a gap, the annular frame and the electro-optical circuit form a cavity for placement of a plurality of bonding wires the interconnect that electro-optical circuit to the substrate.
    Type: Grant
    Filed: December 29, 2008
    Date of Patent: May 3, 2011
    Assignees: Texas Instruments Incorporated, Amkor Technology, Inc.
    Inventors: Bradley Morgan Haskett, John Patrick O'Connor, Mark Myron Miller, Sean Timothy Crowley, Jeffery Alan Miks, Mark Phillip Popovich
  • Publication number: 20110098291
    Abstract: Described herein are compounds, pharmaceutical compositions and methods for the inhibition of Hedgehog signaling. Said compounds, pharmaceutical compositions and methods have utility in the treatment of human and veterinary diseases and disorders.
    Type: Application
    Filed: May 4, 2010
    Publication date: April 28, 2011
    Applicant: Alla Chem Inc.
    Inventors: Alexander KHVAT, Sergey TKACHENKO, Ilya OKUN, Borys V. ROGOVOY, Nikolay SAVCHUK, John MAY, Patrick O'CONNOR, William RIPKA, Jean-Michel VERNIER, David MATTHEWS
  • Publication number: 20110053860
    Abstract: The invention relates to compositions and methods for enhancing bone healing, bone formation and wound healing. More specifically, it relates to the use of cyclooxygenase 2 (COX-2) following bone fracture, orthopaedic procedure or wound infliction to enhance healing.
    Type: Application
    Filed: September 3, 2009
    Publication date: March 3, 2011
    Inventor: J. Patrick O'Connor
  • Patent number: 7892568
    Abstract: The invention provides methods and compositions for the detection of Ehrlichia chaffeensis.
    Type: Grant
    Filed: April 13, 2010
    Date of Patent: February 22, 2011
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Thomas Patrick O'Connor, Jr., Jill M. Saucier
  • Patent number: 7888054
    Abstract: The invention provides Ehrlichia canis antigens that can be used to detect E. canis infected animals regardless of whether the animals have been vaccinated for E. canis. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: February 15, 2011
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Eugene Regis Krah, III, Melissa Beall, Thomas Patrick O'Connor, Jr., Ramaswamy Chandrashekar
  • Publication number: 20100330661
    Abstract: The invention provides compositions and methods for the detection and quantification of Ehrlichia ewingii, Ehrlichia ewingii antibodies, antibody fragments, and polypeptides.
    Type: Application
    Filed: June 28, 2010
    Publication date: December 30, 2010
    Inventor: Thomas Patrick O'Connor, JR.
  • Patent number: 7842474
    Abstract: Ehrlichia canis antigens that can be used to differentiate E. canis infected animals from animals that have been challenged with E. canis, e.g., vaccinated against E. canis, are disclosed. The invention also provides compositions and methods for determining the presence of E. canis antigens and antibodies.
    Type: Grant
    Filed: October 4, 2006
    Date of Patent: November 30, 2010
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Eugene Regis Krah, III, Thomas Patrick O'Connor, Jr., Melissa Beall
  • Patent number: 7829535
    Abstract: Methods for promoting osteogenesis to accelerate or enhance bone fracture healing, treat bone defects, and enhance bone formation are disclosed. The methods modulate an arachidonic acid metabolic or signaling pathway in general, and, in particular, utilize 5-lipoxygenase inhibitors. These molecules can be delivered alone or in combination with one or more agents that inhibit bone resorption, regulate calcium resorption from bone, enhance bone accumulation, enhance bone formation, induce bone formation, impair growth of microorganisms, reduce inflammation, and/or reduce pain.
    Type: Grant
    Filed: August 18, 2006
    Date of Patent: November 9, 2010
    Assignee: Accelalox, Inc.
    Inventor: James Patrick O'Connor
  • Publication number: 20100207038
    Abstract: An apparatus for laser irradiation including a housing wherein the housing defines at least a portion of a test volume; a first conduit configured to provide a first flow of gas into the test volume; a second conduit configured to remove the first flow of gas from the test volume; a third conduit configured to provide a second flow of gas; and a flow controller configured to provide a region of increased flow impedance between the first conduit and the third conduit so that the first flow of gas is directed towards the test volume and the second flow of gas is directed away from the first flow of gas so as to restrict gas external to the housing from coming into contact with the first flow of gas.
    Type: Application
    Filed: February 13, 2009
    Publication date: August 19, 2010
    Inventors: Barry Leonard Sharp, Dhinesh Asogan, Ciaran John Patrick O'Connor
  • Publication number: 20100190960
    Abstract: The invention provides methods and compositions for the detection of Ehrlichia chaffeensis.
    Type: Application
    Filed: April 13, 2010
    Publication date: July 29, 2010
    Inventors: Thomas Patrick O'Connor, JR., Jill M. Saucier
  • Patent number: 7763582
    Abstract: A method of promoting bone healing in a non-diabetic patient in need thereof by locally administering a therapeutically effective amount of insulin to the patient. A drug delivery device, which includes insulin and a pharmaceutically acceptable carrier, wherein the device is adapted for localized administration of insulin to a patient in need thereof is also presented.
    Type: Grant
    Filed: February 21, 2007
    Date of Patent: July 27, 2010
    Assignee: University of Medicine and Dentistry Of New Jersey
    Inventors: Sheldon Suton Lin, Ankur Gandhi, James Patrick O'Connor, Loay A. Al-Zube, Joseph Benevenia, J. Russell Parsons
  • Publication number: 20100164081
    Abstract: According to one embodiment, a micro-optical device includes an electro-optical circuit and an annular frame disposed on a surface of a substrate. The electro-optical circuit has an active region that is encapsulated by a window and an interconnect region adjacent at least one edge of the electro-optical circuit. The annular frame extends around an outer periphery of the window and is separated from the window by a gap, the annular frame and the electro-optical circuit form a cavity for placement of a plurality of bonding wires the interconnect that electro-optical circuit to the substrate.
    Type: Application
    Filed: December 29, 2008
    Publication date: July 1, 2010
    Applicant: Texas Instruments Incorporated
    Inventors: Bradley Morgan Haskett, John Patrick O'Connor, Mark Myron Miller, Sean Timothy Crowley, Jeffery Alan Miks, Mark Phillip Popovich
  • Patent number: 7744872
    Abstract: The invention provides compositions and methods for the detection and quantification of Ehrlichia ewingii, Ehrlichia ewingii antibodies, antibody fragments, and polypeptides.
    Type: Grant
    Filed: January 26, 2007
    Date of Patent: June 29, 2010
    Assignee: IDEXX Laboratories, Inc.
    Inventor: Thomas Patrick O'Connor, Jr.
  • Patent number: 7741059
    Abstract: The invention provides methods and compositions for the detection of Ehrlichia chaffeensis.
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: June 22, 2010
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Thomas Patrick O'Connor, Jr., Jill M. Saucier
  • Patent number: 7723062
    Abstract: The invention provides compositions and methods for the detection and quantification of Wolbachia antibodies, antibody fragments, and polypeptides.
    Type: Grant
    Filed: August 20, 2008
    Date of Patent: May 25, 2010
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Thomas Patrick O'Connor, Jr., Jill M. Saucier
  • Patent number: D642166
    Type: Grant
    Filed: April 28, 2010
    Date of Patent: July 26, 2011
    Assignee: Open Range Communications Inc.
    Inventors: William S. Beans, Jr., Shihchieh Chou, John C. Hockemeier, James Patrick O'Connor, Keith D. Paglusch